Archival of Human Biological Samples in CU-Med Biobank
NCT04706481 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2026-03-12
Summary
CU-Med Biobank collaborates with different researchers for collecting and distributing human biospecimens and clinical data for assisting scientific research.
Conditions
- Healthy
- Cancer
- Heart Diseases
- Neurological Diseases or Conditions
- Kidney Diseases
- Diabetes
- Other Disease
Interventions
- PROCEDURE
-
Specimen Collection
Specimens obtained from surgical, phlebotomy or other non-invasive procedure
Sponsors & Collaborators
-
Chinese University of Hong Kong
lead OTHER
Principal Investigators
-
Ching Wan MA, MB BChir · Chinese University of Hong Kong
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-01-01
- Primary Completion
- 2050-12-01
- Completion
- 2050-12-01
Countries
- Hong Kong
Study Locations
More Related Trials
-
Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old
NCT06058416 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Risk Factors and Characteristics of COVID 19 Infection in Patients With Haematological Diseases
NCT04930731 ·Status: UNKNOWN
-
A Clinical Research on Disease Progression and Intervention of Chronic HepatitisB
NCT05057065 ·Status: UNKNOWN
-
Research on the Monitoring, Pathogen Screening, and Diagnostic System for Unexplained and Newly Emerging Acute Hepatitis
NCT06653140 ·Status: NOT_YET_RECRUITING
-
GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method)
NCT05668793 ·Status: UNKNOWN
-
A Study to Evaluate Vaccines Against COVID-19 in the Real World
NCT04775056 ·Status: WITHDRAWN
-
Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
NCT04496141 ·Status: COMPLETED
-
Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation
NCT06853886 ·Status: RECRUITING ·Phase: NA
-
Pilot Study of Metabolic Syndromes and HIV Infections in Indian Tibetans
NCT01261221 ·Status: COMPLETED
-
Antibody Response to COVID-19 Vaccines in Liver Disease Patients
NCT04775069 ·Status: COMPLETED ·Phase: PHASE4
-
Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion
NCT06550622 ·Status: RECRUITING
-
Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment
NCT03577938 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong
NCT02443233 ·Status: COMPLETED
-
Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) Infection
NCT01107483 ·Status: COMPLETED
-
COVID-19 Vaccines in Patients With Chronic Liver Disease
NCT05017805 ·Status: UNKNOWN ·Phase: NA
-
Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients
NCT04356404 ·Status: TERMINATED
-
Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies
NCT00004851 ·Status: COMPLETED
-
Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta
NCT04170452 ·Status: UNKNOWN
-
A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B
NCT03108794 ·Status: RECRUITING
-
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
NCT05272735 ·Status: TERMINATED ·Phase: PHASE4
-
Quality of Life and Health Utility of Patients With CHB Infections
NCT03329820 ·Status: COMPLETED
-
HELIO Liver Test Performance Study in China (HEPATIC)
NCT05053412 ·Status: COMPLETED
-
Immune Response in Patients With Hepatitis B and C Infection
NCT02275221 ·Status: RECRUITING
-
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
NCT04032392 ·Status: UNKNOWN ·Phase: PHASE1
-
Hepatitis B and C Within the Chinese Community in Milan
NCT07241962 ·Status: NOT_YET_RECRUITING